Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saray Stancic

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Lifestyle Medicine|October 5, 2018
From Infectious Diseases to Lifestyle Medicine: My Personal JourneySaray Stancic
American Journal of Lifestyle Medicine|July 21, 2022
Six Applications of Plant Based Diets for Health PromotionSaray Stancic, Josh Cullimore, Neal Barnard
The American Journal of Medicine|October 6, 2021
Shoring Up Vaccine EfficacySaray Stancic, Josh Cullimore, Neal D Barnard
Journal of Hepatology|May 24, 2003
Severe migraine headaches are caused by ribavirin but not by interferon alpha-2B in combination therapy for chronic hepatitis CNorbert Bräu, Edmund J Bini, Saray Stancic, et al.
American Journal of Lifestyle Medicine|November 18, 2024
Fast-Food Outlets in Hospitals Affiliated With U.S. Medical SchoolsZeeshan Ali, Saray Stancic, Roxanne Becker, et al.
The American Journal of Gastroenterology|August 23, 2002
Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan areaNorbert Bräu, Edmund J Bini, Azra Shahidi, et al.
HIV Clinical Trials|May 18, 2012
Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trialMaribel Rodriguez-Torres, Jihad Slim, Laveeza Bhatti, et al.
Drug Safety|November 10, 2012
Current challenges and controversies in drug-induced liver injuryAlberto Corsini, Patricia Ganey, Cynthia Ju, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2014
Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR studyEdward J Gane, Paul J Pockros, Stefan Zeuzem, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Lifestyle Medicine|October 5, 2018
From Infectious Diseases to Lifestyle Medicine: My Personal JourneySaray Stancic
American Journal of Lifestyle Medicine|July 21, 2022
Six Applications of Plant Based Diets for Health PromotionSaray Stancic, Josh Cullimore, Neal Barnard
The American Journal of Medicine|October 6, 2021
Shoring Up Vaccine EfficacySaray Stancic, Josh Cullimore, Neal D Barnard
Journal of Hepatology|May 24, 2003
Severe migraine headaches are caused by ribavirin but not by interferon alpha-2B in combination therapy for chronic hepatitis CNorbert Bräu, Edmund J Bini, Saray Stancic, et al.
American Journal of Lifestyle Medicine|November 18, 2024
Fast-Food Outlets in Hospitals Affiliated With U.S. Medical SchoolsZeeshan Ali, Saray Stancic, Roxanne Becker, et al.
The American Journal of Gastroenterology|August 23, 2002
Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan areaNorbert Bräu, Edmund J Bini, Azra Shahidi, et al.
HIV Clinical Trials|May 18, 2012
Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trialMaribel Rodriguez-Torres, Jihad Slim, Laveeza Bhatti, et al.
Drug Safety|November 10, 2012
Current challenges and controversies in drug-induced liver injuryAlberto Corsini, Patricia Ganey, Cynthia Ju, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2014
Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR studyEdward J Gane, Paul J Pockros, Stefan Zeuzem, et al.
Pageof 1